CD8A and neoplasm: Because chemotherapy has been reported to change the tumor microenvironment via high antigen exposure and the accumulation of dendritic cells, which stimulate CD8+ T cells and the type I IFN pathway [24], pre-existing CD8+ TILs may be one of the key components for efficient responses to NAC.